Literature DB >> 14557292

Potential uses of probiotics in clinical practice.

Gregor Reid1, Jana Jass, M Tom Sebulsky, John K McCormick.   

Abstract

Probiotics are defined as live microorganisms that, when administered in adequate amounts, confer a health benefit on the host. There is now mounting evidence that selected probiotic strains can provide health benefits to their human hosts. Numerous clinical trials show that certain strains can improve the outcome of intestinal infections by reducing the duration of diarrhea. Further investigations have shown benefits in reducing the recurrence of urogenital infections in women, while promising studies in cancer and allergies require research into the mechanisms of activity for particular strains and better-designed trials. At present, only a small percentage of physicians either know of probiotics or understand their potential applicability to patient care. Thus, probiotics are not yet part of the clinical arsenal for prevention and treatment of disease or maintenance of health. The establishment of accepted standards and guidelines, proposed by the Food and Agriculture Organization of the United Nations and the World Health Organization, represents a key step in ensuring that reliable products with suitable, informative health claims become available. Based upon the evidence to date, future advances with single- and multiple-strain therapies are on the horizon for the management of a number of debilitating and even fatal conditions.

Entities:  

Mesh:

Year:  2003        PMID: 14557292      PMCID: PMC207122          DOI: 10.1128/CMR.16.4.658-672.2003

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  138 in total

Review 1.  Probiotics: effects on immunity.

Authors:  E Isolauri; Y Sütas; P Kankaanpää; H Arvilommi; S Salminen
Journal:  Am J Clin Nutr       Date:  2001-02       Impact factor: 7.045

2.  Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains.

Authors:  C B Maassen; C van Holten-Neelen; F Balk; M J den Bak-Glashouwer; R J Leer; J D Laman; W J Boersma; E Claassen
Journal:  Vaccine       Date:  2000-05-22       Impact factor: 3.641

3.  Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria.

Authors:  M F Bernet; D Brassart; J R Neeser; A L Servin
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

Review 4.  Probiotics in clinical conditions.

Authors:  Philippe R Marteau
Journal:  Clin Rev Allergy Immunol       Date:  2002-06       Impact factor: 8.667

5.  Antagonistic activity exerted in vitro and in vivo by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection.

Authors:  S Hudault; V Liévin; M F Bernet-Camard; A L Servin
Journal:  Appl Environ Microbiol       Date:  1997-02       Impact factor: 4.792

6.  Lipoteichoic acids from Lactobacillus johnsonii strain La1 and Lactobacillus acidophilus strain La10 antagonize the responsiveness of human intestinal epithelial HT29 cells to lipopolysaccharide and gram-negative bacteria.

Authors:  Karine Vidal; Anne Donnet-Hughes; Dominique Granato
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

7.  [Prevention of traveler's diarrhea with Saccharomyces boulardii. Results of a placebo controlled double-blind study].

Authors:  H Kollaritsch; H Holst; P Grobara; G Wiedermann
Journal:  Fortschr Med       Date:  1993-03-30

8.  Immune protection mediated by the probiotic Lactobacillus rhamnosus HN001 (DR20) against Escherichia coli O157:H7 infection in mice.

Authors:  Quan Shu; Harsharnjit S Gill
Journal:  FEMS Immunol Med Microbiol       Date:  2002-09-06

9.  Oral bacterial therapy reduces the duration of symptoms and of viral excretion in children with mild diarrhea.

Authors:  A Guarino; R B Canani; M I Spagnuolo; F Albano; L Di Benedetto
Journal:  J Pediatr Gastroenterol Nutr       Date:  1997-11       Impact factor: 2.839

10.  Effect of administration of milk fermented with Lactobacillus acidophilus LA-2 on fecal mutagenicity and microflora in the human intestine.

Authors:  M Hosoda; H Hashimoto; F He; H Morita; A Hosono
Journal:  J Dairy Sci       Date:  1996-05       Impact factor: 4.034

View more
  154 in total

Review 1.  Integrative medicine in allergy and immunology.

Authors:  Christopher Chang; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2013-06       Impact factor: 8.667

2.  Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress.

Authors:  M Zareie; K Johnson-Henry; J Jury; P-C Yang; B-Y Ngan; D M McKay; J D Soderholm; M H Perdue; P M Sherman
Journal:  Gut       Date:  2006-04-25       Impact factor: 23.059

3.  Functional foods/ingredients and dental caries.

Authors:  Cor van Loveren; Zdenek Broukal; Edgar Oganessian
Journal:  Eur J Nutr       Date:  2012-07       Impact factor: 5.614

4.  The angiogenic effect of probiotic Bacillus polyfermenticus on human intestinal microvascular endothelial cells is mediated by IL-8.

Authors:  Eunok Im; Yoon Jeong Choi; Cho Hee Kim; Claudio Fiocchi; Charalabos Pothoulakis; Sang Hoon Rhee
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-11       Impact factor: 4.052

5.  A Review of Probiotic Therapy in Preventive Dental Practice.

Authors:  Mark L Cannon
Journal:  Probiotics Antimicrob Proteins       Date:  2011-06       Impact factor: 4.609

6.  Probiotics and Gastrointestinal Disease: Clinical Evidence and Basic Science.

Authors:  Elaine O Petrof
Journal:  Antiinflamm Antiallergy Agents Med Chem       Date:  2009-09-01

7.  Semi-industrial Scale Production of a New Yeast with Probiotic Traits, Cryptococcus sp. YMHS, Isolated from the Red Sea.

Authors:  Ashraf F El-Baz; Hesham A El-Enshasy; Yousseria M Shetaia; Hoda Mahrous; Nor Zalina Othman; Ahmed E Yousef
Journal:  Probiotics Antimicrob Proteins       Date:  2018-03       Impact factor: 4.609

8.  pH-, Lactic acid-, and non-lactic acid-dependent activities of probiotic Lactobacilli against Salmonella enterica Serovar Typhimurium.

Authors:  Domitille Fayol-Messaoudi; Cédric N Berger; Marie-Hélène Coconnier-Polter; Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Appl Environ Microbiol       Date:  2005-10       Impact factor: 4.792

9.  Bacteriotherapy with Lactobacillus plantarum in burns.

Authors:  Maria C Peral; Miguel A Huaman Martinez; Juan C Valdez
Journal:  Int Wound J       Date:  2009-02       Impact factor: 3.315

10.  Potentially probiotic bacteria induce efficient maturation but differential cytokine production in human monocyte-derived dendritic cells.

Authors:  Sinikka Latvala; Taija-E Pietila; Ville Veckman; Riina-A Kekkonen; Soile Tynkkynen; Riitta Korpela; Ilkka Julkunen
Journal:  World J Gastroenterol       Date:  2008-09-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.